Digital Pathology Market Overview
The global digital pathology market is projected to showcase extensive growth during the forecast period, mainly due to increasing adoption of digital pathology products to improve the efficiency of laboratories across the globe, and rising government initiatives in collaboration with market players to raise awareness about the advanced digital pathology products and technologies.
Based on product, the digital pathology market is bifurcated into software, scanner, communication systems, and storage systems. Of these, the market for software products is expected to observe notable growth, as these products are user-friendly and feature analytical and advanced functions for diagnosis purposes.
On the basis of type, the digital pathology market is bifurcated into human pathology and veterinary pathology. Of these two types, the human pathology category dominates the global market and is likely to hold a larger share during the forecast period. This can be ascribed to increasing utilization of digital systems in human pathology; and rise in the number of collaborations between pathology laboratories, and academic institutes and universities.
Based on application, the market is categorized into disease diagnosis, teleconsultation, drug discovery, and training and education. Among various applications, the digital pathology market is expected to observe considerable growth in the teleconsultation application area, owing to increasing demand for quality healthcare and rapid diagnosis of diseases.
Pharmaceutical and biotechnology companies, hospitals and clinics, and academic institutes and research laboratories are the key end users of digital pathology globally. Pharmaceutical and biotechnology companies as an end-user category is expected to hold the largest share in the digital pathology market, as these companies utilize digital pathology for various activities, such as biopharmaceutical studies, biobanking, and molecular assays.
Geographically, North America is expected to be the largest contributor in the digital pathology industry in the coming years, owing to increasing prevalence of chronic diseases, growing healthcare expenditure, and increasing government initiatives in collaboration with market players in diagnostic field.
However, the market in Asia-Pacific is expected to witness the highest growth in demand during the forecast period. This is mainly due to the rapid economic growth, growing pharmaceutical and biotechnology industry, strong presence of small and medium-sized pharmaceutical and biotechnology companies, and increasing government initiatives to raise awareness about digital pathology in the region.
Digital Pathology Market Dynamics
Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases and increasing utilization of digital pathology in drug development are some of the factors propelling the growth of the digital pathology market. According to the World Health Organization (WHO), cancer is the second leading cause of death and is likely to account for an estimated 9.8 million deaths in 2018, globally.
It further stated that, late-stage presentation; and inaccessible diagnosis and treatment are common, and only 26% of low-income countries reported to have pathology services generally available in the public sector, in 2017. With the rising burden of cancer and lack of pathology services in low-income countries, the market for digital pathology is expected to grow during the forecast period. Growing technological advancements in digital pathology plays an important role in the strategic planning of cancer research and precision medicine delivery. Government initiatives are further fueling the growth of the market.
However, high cost of digital pathology systems and lack of standard guidelines are some of the major factors restricting the growth of the digital pathology market.
Integration of laboratory information system (LIS) with digital pathology system (DPS) is expected to boost the adoption of digital pathology system and act as a potential opportunity for the market players to increase their revenue by providing installation and implementation services that integrates both LIS and DPS. Many laboratories are making efforts towards the integration of these systems, which, in turn, should help streamline digital sign-out workflow, minimize unnecessary and error-prone manual work, and reduce delivery cost of glass slides.
Digital Pathology Market Competitive Landscape
Key market players in the digital pathology industry are introducing new digital pathology solutions. For instance, in March 2018, F. Hoffmann-La Roche AG launched VENTANA DP 200 high speed slide scanner for digital pathology. The tray-based design of this scanner is able to produce high-quality images.
Furthermore, in October 2017, Applied Spectral Imaging (ASI), launched PathFusion and HiPath Pro imaging; Brightfield and FISH imaging and analysis solutions for pathology, in order to provide advanced diagnostic services to patients.
Some of the other players in the digital pathology market include Danaher Corporation, Koninklijke Philips N.V., Hamamatsu Photonics, 3DHISTECH Ltd, Apollo Enterprise Imaging Corporation, XIFIN Inc., Huron Digital Pathology, Visiopharm A/S, Corista, and Indica Labs.
The study provides historical as well the forecast market size data for various countries including the U.S., Canada, Germany, France, Italy, Spain, the U.K., Japan, China, India, Brazil, Mexico, Saudi Arabia, South Africa.